Antibodies to squalene in US Navy Persian Gulf War veterans with chronic multisymptom illness

Vaccine

Volumn 27, Issue 29, 2009, Pages 3921-3926

  Phillips, Christopher J ^a   Matyas, Gary R ^b   Hansen, Christian J ^a   Alving, Carl R ^b   Smith, Tyler C ^a   Ryan, Margaret A K ^c  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anthrax vaccines; Immunologic adjuvants; Squalene

Indexed keywords

ANTHRAX VACCINE; ANTIBODY; IMMUNOLOGICAL ADJUVANT; SQUALENE; SQUALENE ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ASSOCIATION; CHRONIC DISEASE; CONSTRUCTION WORK; CONTROLLED STUDY; DILUTION CURVE; ENZYME LINKED IMMUNOSORBENT ASSAY; FATIGUE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MUSCULOSKELETAL PAIN; NAVY; PERSIAN GULF SYNDROME; PRIORITY JOURNAL; QUESTIONNAIRE; UNITED STATES; VETERAN;

ADULT; ANTHRAX VACCINES; ANTIBODIES; HEALTH STATUS; HUMANS; IRAQ WAR, 2003 -; MALE; MIDDLE AGED; SQUALENE; UNITED STATES; VETERANS;

EID: 67349240831     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.03.091     Document Type: Article

References (41)

1. Self-reported illness and health status among Gulf War veterans. A population-based study. The Iowa Persian Gulf Study Group. JAMA 1997;277(January (3)):238-45.
2. Fukuda K., Straus S.E., Hickie I., Sharpe M.C., Dobbins J.G., and Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med 121 December (12) (1994) 953-959
3. Gray G.C., Kaiser K.S., Hawksworth A.W., Hall F.W., and Barrett-Connor E. Increased postwar symptoms and psychological morbidity among U.S. Navy Gulf War veterans. Am J Trop Med Hyg 60 May 5 (1999) 758-766
4. Unwin C., Blatchley N., Coker W., Ferry S., Hotopf M., Hull L., et al. Health of UK servicemen who served in Persian Gulf War. Lancet 353 January (9148) (1999) 169-178
5. Asa P.B., Cao Y., and Garry R.F. Antibodies to squalene in Gulf War syndrome. Exp Mol Pathol 68 February (1) (2000) 55-64
6. Fulco C.E., Liverman C.T., and Sox H.C. Gulf War and health: depleted uranium, pyridostigmine bromide, sarin, vaccines (2000), National Academy Press, Washington, DC
7. Chan K.-C. Gulf War illnesses: questions about the presence of squalene antibodies in veterans can be resolved (1999), United States General Accounting Office, Washington, DC
8. Steele L. Prevalence and patterns of Gulf War illness in Kansas veterans: association of symptoms with characteristics of person, place, and time of military service. Am J Epidemiol 152 November (10) (2000) 992-1002
9. Matyas G.R., Rao M., and Alving C.R. Induction and detection of antibodies to squalene. II. Optimization of the assay for murine antibodies. J Immunol Methods 267 2 (2002 Sep 15) 119-129
10. Matyas G.R., Rao M., Pittman P.R., Burge R., Robbins I.E., Wassef N.M., et al. Detection of antibodies to squalene. III. Naturally occurring antibodies to squalene in humans and mice. J Immunol Methods 286 March (1-2) (2004) 47-67
11. Matyas G.R., Wassef N.M., Rao M., and Alving C.R. Induction and detection of antibodies to squalene. J Immunol Methods 245 November (1-2) (2000) 1-14
12. Fedele K. The Seabees go to war. Naval Civil Eng Summer (1991) 3-13
13. Gray G.C., Reed R.J., Kaiser K.S., Smith T.C., and Gastanaga V.M. Self-reported symptoms and medical conditions among 11,868 Gulf War-era veterans: the Seabee Health Study. Am J Epidemiol 155 June (11) (2002) 1033-1044
14. Health Consequences of Service During the Persian Gulf War: Recommendations for Research and Information Systems. Washington, DC: National Academy Press; 1996.
15. Final Report: Defense Science Board Task Force on Persian Gulf War Health Effects. Washington, DC: Office of the Under Secretary of Defense for Acquisition and Technology; 1994.
16. The Persian Gulf experience and health. NIH Technology Assessment Workshop Panel. JAMA 1994;272(August (5)):391-6.
17. DeFraites RF, Wanat E, Norwood A, Williams S, Cowan D, Callahan T. Investigation of a Suspected Outbreak of an Unknown Disease Among Veterans of Operation Desert Shield/Storm, 123rd Army Reserve Command, Fort Benjamin, Harrison, Indiana, April 1992. Washington, DC: Division of Preventive Medicine, Walter Reed Army Institute of Research; 1992.
18. Larrick JW, Raubitschek AR, Truitt KE. Inventor Human Lymphoblastold Cell Line and Hybridoma Derived Thereform; 1986.
19. Teng N.N., Kaplan H.S., Hebert J.M., Moore C., Douglas H., Wunderlich A., et al. Protection against gram-negative bacteremia and endotoxemia with human monoclonal IgM antibodies. Proc Natl Acad Sci USA 82 March (6) (1985) 1790-1794
20. Aggarwal B.B., Moffat B., and Harkins R.N. Human lymphotoxin. Production by a lymphoblastoid cell line, purification, and initial characterization. J Biol Chem 259 January (1) (1984) 686-691
21. Gottschalk P.G., and Dunn J.R. The five-parameter logistic: a characterization and comparison with the four-parameter logistic. Anal Biochem 343 August (1) (2005) 54-65
22. Plikaytis B.D., Turner S.H., Gheesling L.L., and Carlone G.M. Comparisons of standard curve-fitting methods to quantitate Neisseria meningitidis group A polysaccharide antibody levels by enzyme-linked immunosorbent assay. J Clin Microbiol 29 July (7) (1991) 1439-1446
23. Unexplained illness among Persian Gulf War veterans in an Air National Guard Unit: preliminary report-August 1990-March 1995. MMWR Morb Mortal Wkly Rep 1995;44(June (23)):443-7.
24. Shawky S. Depleted uranium: an overview of its properties and health effects. East Mediterr Health J 8 March-May (2-3) (2002) 432-439
25. Kalra R., Singh S.P., Razani-Boroujerdi S., Langley R.J., Blackwell W.B., Henderson R.F., et al. Subclinical doses of the nerve gas sarin impair T cell responses through the autonomic nervous system. Toxicol Appl Pharmacol 184 October (2) (2002) 82-87
26. Sartin J.S. Gulf War illnesses: causes and controversies. Mayo Clin Proc 75 August (8) (2000) 811-819
27. Abou-Donia M.B., Wilmarth K.R., Abdel-Rahman A.A., Jensen K.F., Oehme F.W., and Kurt T.L. Increased neurotoxicity following concurrent exposure to pyridostigmine bromide, DEET, and chlorpyrifos. Fundam Appl Toxicol 34 December (2) (1996) 201-222
28. Kurt T.L. Epidemiological association in US veterans between Gulf War illness and exposures to anticholinesterases. Toxicol Lett December (102-103) (1998) 523-526
29. Hotopf M., David A., Hull L., Ismail K., Unwin C., and Wessely S. Role of vaccinations as risk factors for ill health in veterans of the Gulf war: cross sectional study. BMJ 320 May (7246) (2000) 1363-1367 [see comment]
30. Taylor D.N., Sanchez J.L., Smoak B.L., and DeFraites R. Helicobacter pylori infection in Desert Storm troops. Clin Infect Dis 25 November (5) (1997) 979-982
31. Haley R.W., Hom J., Roland P.S., Bryan W.W., Van Ness P.C., Bonte F.J., et al. Evaluation of neurologic function in Gulf War veterans. A blinded case-control study. JAMA 277 January (3) (1997) 223-230
32. Haley R.W., and Kurt T.L. Self-reported exposure to neurotoxic chemical combinations in the Gulf War. A cross-sectional epidemiologic study. JAMA 277 January (3) (1997) 231-237
33. Haley R.W., Kurt T.L., and Hom J. Is there a Gulf War Syndrome? Searching for syndromes by factor analysis of symptoms. JAMA 277 January (3) (1997) 215-222
34. Hyams K.C., and Roswell R.H. Resolving the Gulf War syndrome question. Am J Epidemiol 148 August (4) (1998) 339-342
35. Alving C.R., and Grabenstein J.D. Re: antibodies to squalene in Gulf War Syndrome. Exp Mol Pathol 68 June (3) (2000) 196-198
36. Del Giudice G., Fragapane E., Bugarini R., Hora M., Henriksson T., Palla E., et al. Vaccines with the MF59 adjuvant do not stimulate antibody responses against squalene. Clin. Vaccine Immunol. 13 September (9) (2006) 1010-1013
37. Spanggord R.J., Sun M., Lim P., and Ellis W.Y. Enhancement of an analytical method for the determination of squalene in anthrax vaccine adsorbed formulations. J Pharm Biomed Anal 42 October (4) (2006) 494-499
38. Lees-Haley P.R., and Brown R.S. Biases in perception and reporting following a perceived toxic exposure. Percept Mot Skills 75 October (2) (1992) 531-544
39. Southwick S.M., Morgan III C.A., Nicolaou A.L., and Charney D.S. Consistency of memory for combat-related traumatic events in veterans of Operation Desert Storm. Am J Psychiatry 154 February (2) (1997) 173-177
40. McCauley L.A., Joos S.K., Spencer P.S., Lasarev M., and Shuell T. Strategies to assess validity of self-reported exposures during the Persian Gulf War. Portland Environmental Hazards Research Center. Environ Res 81 October (3) (1999) 195-205
41. Gray G.C., Hawksworth A.W., Smith T.C., Kang H.K., Knoke J.D., and Gackstetter G.D. Gulf War Veterans' Health Registries. Who is most likely to seek evaluation?. Am J Epidemiol 148 August (4) (1998) 343-349